kainos loboratories,inc Logo

kainos loboratories,inc

Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.

4556 | T

Overview

Corporate Details

ISIN(s):
JP3205650009
LEI:
Country:
Japan
Address:
文京区本郷二丁目38番18号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kainos Laboratories, Inc., founded in May 1975, is a company engaged in the research, development, manufacturing, and sale of clinical diagnostic products. It specializes in innovative clinical testing reagents, including biochemical and immunochemistry diagnostics, and also handles pharmaceuticals. The company's operations encompass the entire product lifecycle, from R&D to marketing, distribution, and import/export activities. Kainos Laboratories positions itself as a pioneer in its field, focused on creating innovative medical diagnostic tools for the healthcare industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 02:17
Registration Form
確認書
Japanese 8.1 KB
2025-11-06 02:16
Interim Report
半期報告書-第51期(2025/04/01-2026/03/31)
Japanese 157.7 KB
2025-06-20 03:02
Governance Information
内部統制報告書-第50期(2024/04/01-2025/03/31)
Japanese 21.9 KB
2025-06-20 03:00
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 02:59
Annual Report
有価証券報告書-第50期(2024/04/01-2025/03/31)
Japanese 710.6 KB
2025-06-20 02:56
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2024-11-06 01:39
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-11-06 01:38
Interim Report
半期報告書-第50期(2024/04/01-2025/03/31)
Japanese 160.1 KB
2024-06-21 03:08
Post-Annual General Meeting Information
臨時報告書
Japanese 22.5 KB
2024-06-21 03:06
Governance Information
内部統制報告書-第49期(2023/04/01-2024/03/31)
Japanese 21.1 KB
2024-06-21 03:04
Registration Form
確認書
Japanese 8.1 KB
2024-06-21 03:02
Annual Report
有価証券報告書-第49期(2023/04/01-2024/03/31)
Japanese 704.8 KB
2024-02-02 01:39
Report Publication Announcement
確認書
Japanese 8.0 KB
2024-02-02 01:38
Quarterly Report
四半期報告書-第49期第3四半期(2023/10/01-2023/12/31)
Japanese 135.5 KB
2023-11-02 02:27
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all kainos loboratories,inc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for kainos loboratories,inc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for kainos loboratories,inc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea
014570
Korro Bio, Inc. Logo
A clinical-stage biopharma using RNA editing to develop medicines for rare & prevalent diseases.
United States of America
KRRO
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan
4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan
4884
Krka Logo
Develops and sells generic prescription, non-prescription, and animal health products globally.
Slovenia
KRKG
Krystal Biotech, Inc. Logo
Developing redosable gene therapies for rare diseases using a modified HSV-1 vector.
United States of America
KRYS
KUKJEON PHARMACEUTICAL Co.,Ltd Logo
A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.
South Korea
307750
Kura Oncology, Inc. Logo
Develops targeted precision medicines for high-need cancers like leukemia, head & neck, and lung cancer.
United States of America
KURA
KWANGDONG PHARMACEUTICAL CO.,LTD Logo
Developing drugs & health goods by integrating oriental and Western medicine.
South Korea
009290
Kyivmedpreparat Logo
A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.
Ukraine
KMED

Talk to a Data Expert

Have a question? We'll get back to you promptly.